Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Design Therapeutics, Inc. - Common Stock (NQ:DSGN)

12.82 +0.06 (+0.51%)
Streaming Delayed Price Updated: 11:09 AM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Design Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Why Shares of Design Therapeutics Are Plummeting on Tuesday ↗
The biotech company released phase 1 trial details regarding a Friedreich ataxia therapy. 
Via The Motley Fool
News headline image
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Down 2%; Home Depot Posts Upbeat Earnings ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 90 points on Tuesday. The Dow traded down 0.75% to 35,042.16 while the NASDAQ fell 0.66% to 13,697.15. The S&P... 
Via Benzinga
Topics Stocks
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 ↗
 
Via Benzinga
News headline image
Dow Falls Over 200 Points; US Retail Sales Top Expectations ↗
U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.67% to 35,069.60 while the NASDAQ fell... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is Design Therapeutics Stock Moving Lower Today? ↗
Design Therapeutics Inc (NASDAQ: DSGN) reported initial results from the company's Phase 1 multiple-ascending dose (MAD) clinical trial of DT-216 in  
Via Benzinga
News headline image
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket ↗
Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday! 
Via InvestorPlace
News headline image
Design Therapeutics, Getty Images, Sea Limited And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
From Design Therapeutics, Inc.
Via GlobeNewswire
News headline image
Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
From Design Therapeutics, Inc.
Via GlobeNewswire
News headline image
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated ↗
Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of  
Via Benzinga
News headline image
Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Design Therapeutics to Present at the 2023 Jefferies Healthcare Conference
From Design Therapeutics, Inc.
Via GlobeNewswire
News headline image
Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial Results
From Design Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023 ↗
 
Via Benzinga
News headline image
Design Therapeutics to Present Preclinical Data on its GeneTAC™ Small Molecule, DT-168, for the Treatment of Fuchs Endothelial Corneal Dystrophy at ARVO 2023
From Design Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Design Therapeutics (DSGN) Stock Is Going Nowhere But Down ↗
Design Therapeutics has multiple research programs and a strong drive to combat genetic disorders, but that's not enough to save DSGN stock. 
Via InvestorPlace
News headline image
Short Squeeze Stocks: BBBY, SI and 3 Other Stocks Ready to Squeeze ↗
Short squeeze stocks are all over Wall Street in the wake of the regional banking crisis. Which names should you keep an eye out for? 
Via InvestorPlace
News headline image
Short Interest Update - Monday, March 27 ↗
Although equities broadly are starting the new week higher, the most heavily shorted stocks are trading lower today. 
Via Talk Markets
News headline image
First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday ↗
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp. 
Via Benzinga
News headline image
Design Therapeutics Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
From Design Therapeutics, Inc.
Via GlobeNewswire
News headline image
Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Design Therapeutics, Inc. (NASDAQ:DSGN) Investor Alert: Investigation Concerning Possible Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 03/08/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Design Therapeutics, Inc. 
Via SBWire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 35 stocks hit new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.